Generic products having at most 15% lower price than the originals

Pharmaceutical companies’ strategies to register prices of generic products lower than the originals seem to settle in the pharmaceutical industry. Among the 10 newly registered products on the 1^stof the next month, one of them has been set to the‘Estimated Sale Cost’.

In this competition, complexes of improved drugs are also involved, and renewals of lowest prices in same components have been...